ARCHIVES

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

This article is from The Cancer Letter archive.

Vol. 10 No. 41 | October 26, 1984

Download PDF Visit The Full Archive

Related Articles

DCCR Free Up $5 Million; New Policy Limits Core Support

November 5, 1976

Danish Researchers Post Long-Awaited Aranesp Results–Ever So Discreetly.

February 16, 2007

NCI Cancer Prevention Fellowship Program

April 28, 2000

NIH Limits Increases In Competing Renewals To Biomedical Deflator

August 30, 1991

In Brief: NCI Monograph On Year 2000 Objectives Now Available; Radiation Accident Workshop Planned

October 31, 1986

DCT Board Approves Concepts Of Five Contract Recompetitions

October 14, 1983